Literature DB >> 2059706

Sensorineural hearing loss with low dose erythromycin.

E Kemp, S Keidar, J G Brook.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2059706      PMCID: PMC1670016          DOI: 10.1136/bmj.302.6788.1341-c

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

1.  Ototoxicity of erythromycin in peritoneal dialysis patients.

Authors:  R Taylor; I S Schofield; J M Ramos; A J Bint; M K Ward
Journal:  Lancet       Date:  1981-10-24       Impact factor: 79.321

2.  Ototoxic effect of erythromycin therapy.

Authors:  V G Schweitzer; N R Olson
Journal:  Arch Otolaryngol       Date:  1984-04

3.  Ototoxicity of erythromycin.

Authors:  W F van Marion; J W van der Meer; M W Kalff; S M Schicht
Journal:  Lancet       Date:  1978-07-22       Impact factor: 79.321

4.  Ototoxicity of erythromycin in patients with renal insufficiency.

Authors:  J P Méry; A Kanfer
Journal:  N Engl J Med       Date:  1979-10-25       Impact factor: 91.245

5.  Reversible sensorineural hearing loss with intravenous erythromycin lactobionate.

Authors:  C S Karmody; L Weinstein
Journal:  Ann Otol Rhinol Laryngol       Date:  1977 Jan-Feb       Impact factor: 1.547

6.  Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysis.

Authors:  P D Kroboth; M A McNeil; A Kreeger; J Dominguez; R Rault
Journal:  Arch Intern Med       Date:  1983-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.